Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
about
Pooled protein immunization for identification of cell surface antigens in Streptococcus sanguinisIdentification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization.Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice.Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS)Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study.Emergence of novel Streptococcus iniae exopolysaccharide-producing strains following vaccination with nonproducing strains.Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.C-terminal WxL domain mediates cell wall binding in Enterococcus faecalis and other gram-positive bacteria.IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr miceGenetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development.Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal DiseaseNasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice.Diverse evolutionary patterns of pneumococcal antigens identified by pangenome-wide immunological screening.Current status and perspectives on protein-based pneumococcal vaccines.Pneumococcal lipoproteins involved in bacterial fitness, virulence, and immune evasion.Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.The rgg gene is a specific marker for Streptococcus oralis.Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9.Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection.Pneumococcal Predictive Proteins Selected by Microbial Genomic Approach Are Serotype Cross-Reactive and Bind to Host Extracellular Matrix Proteins.The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.Identification of a pheA gene associated with Streptococcus mitis by using suppression subtractive hybridization.The streptococcal Blr and Slr proteins define a family of surface proteins with leucine-rich repeats: camouflaging by other surface structures.Localization of PcsB of Streptococcus pneumoniae and its differential expression in response to stress.Evaluating the protective efficacy of antigen combinations against Photobacterium damselae ssp. piscicida infections in cobia, Rachycentron canadum L.Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection.Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
P2860
Q33644475-5B980C13-192D-4E8B-AC30-77D7456F16E9Q33826031-1E1CFB72-7C31-49CE-A841-DDF68E28D74EQ33963100-564ABEDE-D177-45FD-BA48-569E5198AF49Q34033151-BC0DF964-FD8E-406F-ADCD-0ABB652B0C2EQ34529480-DA04C7F6-F727-4722-ADAA-243C327D85CFQ34659957-FF825EFB-4CF1-4A83-BA6C-D31BF24441B6Q34740228-1D4F5E19-A211-40D0-B096-4C963F03F45BQ34832780-997302D8-8DD4-408B-8848-A6051EC062FCQ34975824-7BE2692A-6906-4B6A-B3D4-E431823A1F88Q35634681-CCBC825D-F4B5-47A6-9BDE-23BEFA207E95Q35800361-20FB645E-A38F-4E22-815D-704B016EA7E1Q35886867-48EF4F80-2DDE-44AA-B976-5EEC6A4F73F6Q36282841-023171C7-176F-44D2-B9E5-12BC249E9BBEQ36710606-F49B6FFD-FDC7-435E-9ED4-8B1DB66ADD3DQ37598959-4C0793A4-B66D-4B6E-8374-552DBBB3989FQ38124921-FCDBA95D-271D-4922-AD24-EE66305C7B1EQ38923654-8B55EB9D-8161-4311-B29A-8E857606B686Q39164566-E742F161-9E09-4871-B7C1-2E957A655071Q39844043-BEEA3D84-3BB0-4F82-B8E3-8B1E80BFBF8AQ40015954-B92BD19A-00B6-4E4E-B378-FE9C388C6FFEQ40240545-6AFD4222-BCED-4A4D-9C87-83EC1509501DQ40328473-125E0185-7FDA-4419-A646-8F6B11C10FF2Q40332317-7A2A7D1D-5C04-4BA6-9B97-049446616F4FQ42119996-2791F97D-19D1-4936-96BC-1D8B44288E62Q42137491-65EA383B-58CD-44B8-9BCB-1F631F019070Q42620367-D60257B3-0423-4A32-8EFF-A7502DE6A290Q43424179-9B5234ED-4917-454C-8D05-63DCB02306A8Q44002546-D2986B23-EA58-457A-BE5C-844EA0D3DDD3Q46120618-2F9AC373-4438-46A5-88B5-412C948E0A9BQ58596157-8F08C3B5-6532-4AA9-B666-0132587CD969
P2860
Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Relationship between surface a ...... n by Streptococcus pneumoniae.
@en
type
label
Relationship between surface a ...... n by Streptococcus pneumoniae.
@en
prefLabel
Relationship between surface a ...... n by Streptococcus pneumoniae.
@en
P2093
P2860
P1476
Relationship between surface a ...... n by Streptococcus pneumoniae.
@en
P2093
David E Briles
Dennis O Gor
Michael R Jacobs
Neil S Greenspan
Xuedong Ding
P2860
P304
P356
10.1128/IAI.73.3.1304-1312.2005
P407
P577
2005-03-01T00:00:00Z